Navigation Links
Zebrafish swim into drug development
Date:1/21/2010

By combining the tools of medicinal chemistry and zebrafish biology, a team of Vanderbilt investigators has identified compounds that may offer therapeutic leads for bone-related diseases and cancer.

The findings, reported in ACS Chemical Biology, support using zebrafish as a novel platform for drug development.

In 2007, Charles Hong, M.D., Ph.D., and colleagues described using fish embryos to screen for compounds that interfere with signaling pathways involved in early development pathways known to play roles in a variety of disease processes. They discovered the compound "dorsomorphin" and demonstrated that it blocked BMP (bone morphogenetic protein) signaling, which has been implicated in anemia, inflammatory responses and bone-related disorders.

But in examining dorsomorphin further, the investigators found that it had other "off-target" effects it also blocked the VEGF (vascular endothelial growth factor) receptor and disrupted zebrafish blood vessel development, a process called angiogenesis.

"Off-target effects contribute to side effects and limit the therapeutic potential of small molecule signaling inhibitors," said Hong, assistant professor of Medicine and Pharmacology.

To find compounds that were more selective BMP inhibitors (didn't have the off-target effects), Hong and colleagues opted to use their zebrafish drug discovery screen as a drug development/optimization tool.

Craig Lindsley, Ph.D., director of Medicinal Chemistry for the Vanderbilt Program in Drug Discovery, Corey Hopkins, Ph.D., associate director, and their colleagues used the dorsomorphin "backbone" as a starting point to synthesize many different analogs subtly different dorsomorphin-like compounds.

Then Hong and his team tested these compounds for their effects on zebrafish embryonic development.

"We quickly discovered that the two effects of dorsomorphin could be separated some analogs only affected
'/>"/>

Contact: Leigh MacMillan
leigh.macmillan@vanderbilt.edu
615-322-4747
Vanderbilt University Medical Center
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. Drug-proof zebrafish reveal secrets of addiction
2. Pitt team finds molecule that regulates heart size by using zebrafish screening model
3. Zebrafish provide a model for cancerous melanoma in humans
4. Alzheimer cell death in Zebrafish: Demise of neurons observed live for the first time
5. AZTI-Tecnalia coordinates a platform promoting the use of zebrafish in scientific research
6. NIH grants Phylonix Phase II SBIR to develop high-throughput in vivo zebrafish assays
7. Digital zebrafish embryo provides the first complete developmental blueprint of a vertebrate
8. Deadly genetic disease prevented before birth in zebrafish
9. A screening strategy using zebrafish targets genes that protect against hearing loss
10. Study shows how the zebrafish gets his stripe
11. Zebrafish to shed light on human mitochondrial diseases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/21/2014)... -- Nine researchers from Beth Israel Deaconess ... in "The World,s Most Influential Scientific Minds 2014," ... Thomson Reuters ScienceWatch, a web resource for science metrics ... recognized as among the most influential "are performing and ... the advancement of their science," according to a Thomson ...
(Date:8/21/2014)... Fram Strait is a key region in the global oceanic ... and Svalbard warm Atlantic water flows to the north into ... water masses and sea ice push their way out of ... the Atlantic water cools here on its way to the ... water caused in this manner drives the global band of ...
(Date:8/21/2014)... Wednesday, Oct. 18-22, 2014 , WHERE: , ... San Diego, CA 92101 , WHAT: , ... of the latest research in human genetics. Examples ... high-scoring abstracts on rare genetic variants in health ... treatment for sun sensitivity (Saturday, Oct. 18, 5:30-7:30 ...
Breaking Biology News(10 mins):BIDMC researchers named among 'the most influential scientific minds' 2BIDMC researchers named among 'the most influential scientific minds' 3Arctic sea ice influenced force of the Gulf Stream 2Arctic sea ice influenced force of the Gulf Stream 3American Society of Human Genetics 2014 Annual Meeting 2
... 8, 2009 / b3c newswire / - West ... and systems for injectable drug delivery, and Vetter, ... manufacturing of prefilled application systems, have introduced a ... products. , “The Vetter/West WFI syringe combines the ...
... Ore Oregon Health & Science University researchers, along ... uncovering new information about the mind by studying the ... this research will one day provide new tools for ... treatments. The researchers, latest findings are published in the ...
... lesson from Australia,s Great Barrier Reef is that we ... turn protects us. That,s the message from Professor ... Coral Reef Studies and James Cook University who today ... for his pioneering work in understanding how ecosystems develop ...
Cached Biology News:Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution 2Prefilled WFI Syringe Provides a High-Quality Solution for Drug Reconstitution 3OHSU researchers study the idling brain 2A big lesson from the reef 2A big lesson from the reef 3
(Date:8/20/2014)... 20, 2014 Neurotrope, Inc. (OTCQB: NTRP) ... call to provide an update on Company activities. ... timeDial-in numbers:(888) 505-4369 (U.S. and Canada) or (719) ... www.neurotropebioscience.com , under "Investor Relations"The teleconference replay will ... September 2, 2014 at (888) 203-1112 (U.S. and ...
(Date:8/20/2014)... 2014 The 6th Annual Arrowhead ... on October 29-30 in San Francisco, CA. This year’s ... government researchers and clinicians focused on addressing and solving ... In the twelve years since the sequencing of the ... introduced with pharmacogenetic information in the label and molecular ...
(Date:8/20/2014)... WriteResult®, a leading provider of Electronic Patient ... its myPROpad™ ePRO tablet with the addition of a ... most widely used and well-respected Patient Reported Outcome (PRO) ... is used during clinical trials and in other health ... used to demonstrate Health-Related Quality of Life outcomes (HRQoL) ...
(Date:8/19/2014)... 19, 2014 Research and Markets  has announced the ... Strategic Business Report" report to their offering. ... Supplies in US$ Thousands by the following Product Segments: Media, Sera, ... the US, Canada , Japan ... and Latin America . Annual estimates and forecasts ...
Breaking Biology Technology:Neurotrope To Host Conference Call 26th Annual Personalized and Precision Medicine Conference Bringing Together Thought Leaders to Discuss Clinical Implementation, Dx Reimbursement, Big Data, and Sequencing 2EQ-5D™ Assessment Now Available for iPad 2Global Cell and Tissue Culture Supplies - Strategic Business Report 2014 2
... Offers New Intravaginal Foam Technology with Improved Usability & ... ... May 13 Despite the high incidence,of women,s health conditions that ... ovules, a recent survey,found that an alarming majority of women find ...
... Has Four Phase 2 Trials Underway, MONTVALE, N.J., ... has dosed the first patient in a 160-patient Phase ... BREAK (Beginning a,Randomized Evaluation of the A.G.E. [Advanced Glycation ... randomized,double-blind, placebo controlled study to assess the effect of ...
... Technologies,Inc. (Amex: PTN ) today reported its ... 2008 and announced new strategic objectives as part ... development,programs. Palatin will continue to develop products targeting ... and,cardiovascular fields, including acute hospital care products for ...
Cached Biology Technology:72% of Women Are Dissatisfied With Their Current Treatment of Vaginal Infection, Survey Finds 2Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 2Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 3Synvista Therapeutics Announces Initiation of the BREAK Study of Alagebrium for Diastolic Heart Failure 4Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 2Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 3Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 4Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 5Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 6Palatin Technologies Announces New Strategic Objectives and Reports Third Quarter 2008 Financial Results 7
...
... Anti-HMGN2/HMG-17 Immunogen : ... Tris-glycine, pH7.4, 5mg/ml BSA, 0.15M ... the addition of glycerol to ... by immunoblot on acid extracts ...
...
... different human fetal normal tissues are ... upon request. Customers can choose ... set, and pay 70% of the ... P Set products are for research ...
Biology Products: